Back Pain and Male Sexual Disfunction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by Bezmialem Vakif University.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
gokcen basaranoglu, Bezmialem Vakif University
ClinicalTrials.gov Identifier:
NCT01420731
First received: August 19, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
  Purpose

Back pain is a common hormonal disorder in men that may affect the phases of male sexual function. The investigators investigated sexual function in male patients with back pain.

A total of 54 men with back pain and 27 age matched voluntary healthy men who served as the as control group were evaluated with a detailed medical and sexual history, including a international erectile function index (IEFI) questionnaire and the Beck Depression Inventory. Serum prolactin, dehydroepiandrosterone sulfate, free testosterone, androstenedione, 17alpha-hydroxyprogesterone, estradiol, free thyroxin and thyrotropin were measured. These variables were compared statistically between the 2 groups.


Condition
Marriage, Life Event

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Phase 4 Study Back Pain and Male Sexual Disfunction

Resource links provided by NLM:


Further study details as provided by Bezmialem Vakif University:

Estimated Enrollment: 54
Study Start Date: September 2011
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Detailed Description:

A total of 54 men with back pain and 27 age matched voluntary healthy men who served as the as control group were evaluated with a detailed medical and sexual history, including a international erectile function index (IEFI) questionnaire and the Beck Depression Inventory. Serum prolactin, dehydroepiandrosterone sulfate, free testosterone, androstenedione, 17alpha-hydroxyprogesterone, estradiol, free thyroxin and thyrotropin were measured. These variables were compared statistically between the 2 groups.

  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

20-45 years old,male patients with active sexual life

Criteria

Inclusion Criteria:

  • Male patient with back pain
  • 20 - 45 years old
  • Active sexual life

Exclusion Criteria:

  • Younger than 20, older than 45 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01420731

Contacts
Contact: Gokcen Basaranoglu, MD 90 532 589 98 71 gbasaranoglu@hotmail.com

Locations
Turkey
Bezmialem Vakif University Not yet recruiting
Istanbul, Turkey, 34093
Contact: Gokcen Basaranoglu, MD    90 532 89 98 71    gbasaranoglu@hotmail.com   
Principal Investigator: Gokcen Basranoglu, MD         
Sponsors and Collaborators
Bezmialem Vakif University
Investigators
Principal Investigator: Gökçen Başaranoğlu, MD Beazialem Vakıf University
  More Information

No publications provided

Responsible Party: gokcen basaranoglu, MD, Bezmialem Vakif University
ClinicalTrials.gov Identifier: NCT01420731     History of Changes
Other Study ID Numbers: gbms1
Study First Received: August 19, 2011
Last Updated: August 19, 2011
Health Authority: Turkey: Ethics Committee

Keywords provided by Bezmialem Vakif University:
sexual life, back pain

Additional relevant MeSH terms:
Back Pain
Sexual Dysfunctions, Psychological
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Sexual and Gender Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 24, 2014